A prospective randomized controlled trial of preoperative whole-liver chemolipiodolization for hepatocellular carcinoma

Digestive Diseases and Sciences

Volumn 57, Issue 5, 2012, Pages 1404-1412

  Kaibori, Masaki ^a   Nakahashi, Yoshitsugu ^a   Sawada, Satoshi ^a   Tanigawa, Noboru ^a   Hirohara, Junko ^a   Okazaki, Kazuichi ^a   Kariya, Shuji ^a   Ikeda, Hiroki ^a   Koreeda, Chizu ^a   Kwon, A Hon ^a   Seki, Toshihito ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Preoperative chemolipiodolization; Randomized controlled trial; Whole liver

Indexed keywords

EPIRUBICIN; GELATIN SPONGE; IODINATED POPPYSEED OIL; ANTINEOPLASTIC AGENT; ETHIODIZED OIL;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHEMOLIPIODOLIZATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TUMOR NECROSIS; UNSPECIFIED SIDE EFFECT; ADJUVANT CHEMOTHERAPY; CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEPATIC ARTERY; INTRAARTERIAL DRUG ADMINISTRATION; LIVER; LIVER RESECTION; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TUMOR RECURRENCE; VASCULARIZATION;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETERIZATION; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; EPIRUBICIN; ETHIODIZED OIL; FEMALE; HEPATECTOMY; HEPATIC ARTERY; HUMANS; INJECTIONS, INTRA-ARTERIAL; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; TREATMENT OUTCOME;

EID: 84863621247     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2029-3     Document Type: Article

References (27)

1. Bosch FX, Ribes J, Borràs J. Epidemiology of primary liver cancer. Semin Liver Dis. 1999;19:271-285.
2. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-94. Lancet. 1997;350:1142-1143.
3. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340: 745-750.
4. Kotoh K, Sakai H, Sakamoto S, et al. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am J Gastroenterol. 1994;89:194-198.
5. Seki T, Wakabayashi M, Nakagawa T, et al. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer. 1994;74:817-825.
6. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006; 243:321-328.
7. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10-24.
8. Nakamura H, Tanaka T, Hori S, et al. Transcatheter embolization of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization. Radiology. 1983;147:401-405.
9. Sakurai M, Okamura J, Kuroda C. Transcatheter chemo-embolization effective for treating hepatocellular carcinoma. A histopathologic study. Cancer. 1984;54:387-392.
10. Harada T, Matsuo K, Inoue T, et al. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg. 1996;224:4-9.
11. Lu CD, Peng SY, Jiang XC, Chiba Y, Tanigawa N. Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas: retrospective analysis of 120 cases. World J Surg. 1999;23:293-300.
12. Sugo H, Futagawa S, Beppu T, Fukasawa M, Kojima K. Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence. World J Surg. 2003;27:1295-1299.
13. Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg. 1997;226:688-703.
14. Uchida M, Kohno H, Kubota H, et al. Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma. World J Surg. 1996;20:326-331.
15. Yamasaki S, Hasegawa H, Kinoshita H, et al. A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res. 1996;87:206- 211.
16. Nagasue N, Kohno H, Tachibana M, Yamanoi A, Ohmori H, El- Assal ON. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with child-turcotte class B and C cirrhosis. Ann Surg. 1999;229:84-90.
17. Wu CC, Ho YZ, Ho WL, Wu TC, Liu TJ, P'eng FK. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg. 1995;82:122- 126.
18. Zhou WP, Lai EC, Li AJ, et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg. 2009; 249:195-202.
19. Kaibori M, Tanigawa N, Matsui Y, Kwon AH, Sawada S, Kamiyama Y. Preoperative chemolipiodolization of the whole liver for hepatocellular carcinoma. Anticancer Res. 2004;24: 1929-1933.
20. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-655.
21. Kwon AH, Ha-Kawa SK, Uetsuji S, Inoue T, Matsui Y, Kamiyama Y. Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology. 1997;25: 426-429.
22. Strasberg SM, Belghiti J, Clavn P-A, et al. The Brisbane 2000 terminology of liver anatomy and resection. Terminology Committee of the International Hepato-Pancreato-Biliary Association. HPB. 2000;2:333-339.
23. Couinaud C, ed. Le Foie: Études Anatomiques et Chirurgicales. Paris: Masson; 1957.
24. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumours. 5th ed. New York: Wiley; 1997.
25. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 1983;148:397-401.
26. Sato Y, Fujiwara K, Ogata I, et al. Transcatheter arterial embolization for hepatocellular carcinoma. Benefits and limitations for unresectable cases with liver cirrhosis evaluated by comparison with other conservative treatments. Cancer. 1985;55:2822-2825.
27. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429-442.